A. Jeffrey Rona's Insider Trades & SAST Disclosures
A. Jeffrey Rona's most recent trade in Ovid Therapeutics Inc was a trade of 3,902 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Feb. 26, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. Jeffrey Rona.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc | Jeffrey A. Rona | CBFO | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 26 Feb 2025 | 3,902 | 67,973 (0%) | 0% | 0.6 | 2,185 | Common Stock |
| Ovid Therapeutics Inc | Jeffrey A. Rona | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 262,500 | 262,500 | - | - | Employee Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Jeffrey A. Rona | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 43,750 | 71,875 (0%) | 0% | 0 | Common Stock | |
| S&W Seed Co | Jeffrey A. Rona | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 12,725 | 20,700 (0%) | 0% | 0 | Common Stock | |
| Ovid Therapeutics Inc | Jeffrey A. Rona | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 315,000 | 315,000 | - | - | Employee Stock Option (right to buy) | |
| Ovid Therapeutics Inc | A. Rona Jeffrey | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 168,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Rona Jeffrey A. | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 28,125 | 28,125 (0%) | 0% | 0 | Common Stock | |
| S&W Seed Co | A. Jeffrey Rona | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 151,525 | 151,525 (0%) | 0% | 0 | Common Stock | |
| Ovid Therapeutics Inc | Jeffrey A. Rona | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Jeffrey A. Rona | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 194,399 | 194,399 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Jeffrey A. Rona | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Jeffrey A. Rona | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges